Business Wire - December 1, 2005
Mary Ann Liebert, founder, president, and CEO of Mary Ann Liebert, Inc., launched the first journal on AIDS in 1985, long before AIDS was considered a major threat to public health. Her vision and continuing commitment to ensure that important research and clinical information is available to those who may not have access to it, led to a policy that these publications are available electronically, for free, in Africa, and parts of Asia, Latin America, Eastern Europe, and the former Soviet Union. "Providing developing nations with access to this cutting-edge research is critical, especially given the current AIDS epidemic in Africa. Knowledge is prevention in itself. In recognition of World AIDS Day, it gives me great pleasure to extend online access to everyone through the end of December," said Mary Ann Liebert.
AIDS Patient Care and STDs (www.liebertpub.com/apc) is an authoritative peer-reviewed journal that is included in the Brandon/Hill library recommendation list of the top 141 medical journals. The Journal spans the full spectrum of HIV disease, diagnosis, treatment, salvage therapies for resistant HIV, prevention, and education. AIDS Research and Human Retroviruses (www.liebertpub.com/aid) is a highly respected, worldwide Journal that covers the multidisciplinary study of retrovirus-associated diseases with emphasis on HIV.
Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy, Viral Immunology, and the book Medication Adherence in HIV/AIDS. Its biotechnology trade magazine, Genetic Engineering News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, newsmagazines, and books is available at www.liebertpub.com.
Contacts
Mary Ann Liebert, Inc., New Rochelle
Cathia Falvey, 914-740-2165
cfalvey@liebertpub.com
051201
BW051206
Copyright © 2005 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .